Effectiveness of Periocular Drug Injection in CATaract Surgery
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
Cystoid macular edema (CME) is a major cause of suboptimal postoperative visual acuity after
cataract surgery. Topical steroidal and nonsteroidal anti-inflammatory drugs (NSAIDs) are
used to prevent CME. However, noncompliance with eye drops may compromise the effectiveness
of treatment. Dropless periocular drug delivery during cataract surgery may improve the
outcomes and cost-effectiveness of cataract surgery, and may alleviate the burden on homecare
organizations.
Phase:
Phase 3
Details
Lead Sponsor:
Luigi Rondas
Collaborator:
European Society of Cataract and Refractive Surgeons